Pfenex to Present at the Jefferies 2018 Global Healthcare Conference
May 30, 2018 09:10 ET
|
Pfenex, Inc.
SAN DIEGO, May 30, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American:PFNX) announced today that it will be presenting at the Jefferies 2018 Global Healthcare Conference in New York City. ...
Pfenex Announces Closing of Public Offering of 7,820,000 Shares of Common Stock Including Full Exercise of Option to Purchase Additional Shares
May 29, 2018 09:10 ET
|
Pfenex, Inc.
SAN DIEGO, May 29, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American:PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology®...
Pfenex Announces Pricing of Offering of 6,800,000 Shares of Common Stock
May 23, 2018 09:10 ET
|
Pfenex, Inc.
SAN DIEGO, May 23, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American:PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology®...
Pfenex Announces Offering of Common Stock
May 22, 2018 16:23 ET
|
Pfenex, Inc.
SAN DIEGO, May 22, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American:PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology®...